Literature DB >> 33165896

Myocardial infarction in the shadow of COVID-19.

Wojciech Wańha1, Maciej Wybraniec2, Agnieszka Kapłon-Cieślicka3, Karolina Kupczyńska4, Piotr Dobrowolski5, Błażej Michalski4, Szymon Darocha6, Justyna Domienik-Karłowicz7, Fabrizio D'Ascenzo8, Maciej Kaźmierski9, Rafał Januszek10, Stanisław Bartuś10, Adam Witkowski11, Dariusz Dudek10, Wojciech Wojakowski9, Miłosz J Jaguszewski12.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33165896      PMCID: PMC8078982          DOI: 10.5603/CJ.2020.0152

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  13 in total

1.  2018 ESC/EACTS Guidelines on myocardial revascularization.

Authors:  Franz-Josef Neumann; Miguel Sousa-Uva; Anders Ahlsson; Fernando Alfonso; Adrian P Banning; Umberto Benedetto; Robert A Byrne; Jean-Philippe Collet; Volkmar Falk; Stuart J Head; Peter Jüni; Adnan Kastrati; Akos Koller; Steen D Kristensen; Josef Niebauer; Dimitrios J Richter; Petar M Seferovic; Dirk Sibbing; Giulio G Stefanini; Stephan Windecker; Rashmi Yadav; Michael O Zembala
Journal:  Eur Heart J       Date:  2019-01-07       Impact factor: 29.983

2.  Long-term effects of the Managed Care After Acute Myocardial Infarction program: an update on a complete 1-year follow-up.

Authors:  Maciej T Wybraniec; Katarzyna Mizia-Stec; Zbigniew Gąsior; Wojciech Wojakowski; Krzysztof S Gołba; Maciej Turski; Krystian Wita
Journal:  Kardiol Pol       Date:  2020-03-24       Impact factor: 3.108

3.  Decline in the number of coronary angiography and percutaneous coronary intervention procedures in patients with acute myocardial infarction in Poland during the coronavirus disease 2019 pandemic.

Authors:  Jacek Legutko; Łukasz Niewiara; Stanisław Bartuś; Sławomir Dobrzycki; Mariusz Gąsior; Marek Gierlotka; Janusz Kochman; Maciej Lesiak; Jerzy Matysek; Andrzej Ochała; Tomasz Pawłowski; Robert Gil; Adam Witkowski
Journal:  Kardiol Pol       Date:  2020-05-27       Impact factor: 3.108

4.  Takotsubo Syndrome in the Setting of COVID-19.

Authors:  Anum S Minhas; Paul Scheel; Brian Garibaldi; Gigi Liu; Maureen Horton; Mark Jennings; Steven R Jones; Erin D Michos; Allison G Hays
Journal:  JACC Case Rep       Date:  2020-05-01

5.  EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.

Authors:  Alaide Chieffo; Giulio G Stefanini; Susanna Price; Emanuele Barbato; Giuseppe Tarantini; Nicole Karam; Raul Moreno; Gill Louise Buchanan; Martine Gilard; Sigrun Halvorsen; Kurt Huber; Stefan James; Franz-Josef Neumann; Helge Möllmann; Marco Roffi; Guido Tavazzi; Josepa Mauri Ferré; Stephan Windecker; Dariusz Dudek; Andreas Baumbach
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

6.  Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.

Authors:  Ovidio De Filippo; Fabrizio D'Ascenzo; Filippo Angelini; Pier Paolo Bocchino; Federico Conrotto; Andrea Saglietto; Gioel Gabrio Secco; Gianluca Campo; Guglielmo Gallone; Roberto Verardi; Luca Gaido; Mario Iannaccone; Marcello Galvani; Fabrizio Ugo; Umberto Barbero; Vincenzo Infantino; Luca Olivotti; Marco Mennuni; Sebastiano Gili; Fabio Infusino; Matteo Vercellino; Ottavio Zucchetti; Gianni Casella; Massimo Giammaria; Giacomo Boccuzzi; Paolo Tolomeo; Baldassarre Doronzo; Gaetano Senatore; Walter Grosso Marra; Andrea Rognoni; Daniela Trabattoni; Luca Franchin; Andrea Borin; Francesco Bruno; Alessandro Galluzzo; Alfonso Gambino; Annamaria Nicolino; Alessandra Truffa Giachet; Gennaro Sardella; Francesco Fedele; Silvia Monticone; Antonio Montefusco; Pierluigi Omedè; Mauro Pennone; Giuseppe Patti; Massimo Mancone; Gaetano M De Ferrari
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

7.  COVID-19: towards controlling of a pandemic.

Authors:  Juliet Bedford; Delia Enria; Johan Giesecke; David L Heymann; Chikwe Ihekweazu; Gary Kobinger; H Clifford Lane; Ziad Memish; Myoung-Don Oh; Amadou Alpha Sall; Anne Schuchat; Kumnuan Ungchusak; Lothar H Wieler
Journal:  Lancet       Date:  2020-03-17       Impact factor: 79.321

8.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.

Authors:  Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry
Journal:  J Am Coll Cardiol       Date:  2020-04-10       Impact factor: 24.094

9.  Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction.

Authors:  Suman Siddamreddy; Ramakrishna Thotakura; Vasuki Dandu; Sruthi Kanuru; Sreenath Meegada
Journal:  Cureus       Date:  2020-04-22

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  4 in total

1.  Impact of COVID-19 on in-hospital cardiac arrest outcomes: An updated meta-analysis.

Authors:  Karol Bielski; Katarzyna Makowska; Adam Makowski; Tomasz Kopiec; Aleksandra Gasecka; Mariola Malecka; Michal Pruc; Zubaid Rafique; Frank W Peacock; Andrea Denegri; Lukasz Szarpak
Journal:  Cardiol J       Date:  2021       Impact factor: 2.737

2.  Cardiopulmonary resuscitation in COVID-19.

Authors:  Jacek Smereka; Andrzej Raczynski; Paweł Wroblewski; Jarosław Baranski
Journal:  Cardiol J       Date:  2021-12-13       Impact factor: 2.737

3.  Heart inflammation risk after COVID-19 vaccine.

Authors:  Lukasz Szarpak; Michal Pruc; Mariusz Koda; Francesco Chirico
Journal:  Cardiol J       Date:  2021-12-13       Impact factor: 2.737

Review 4.  Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review.

Authors:  Mohammad Amjad Hossain; Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2022-01-19       Impact factor: 5.735

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.